Comparison of effect of NB-UVB with and without topical Latanoprost solution or placebo in Vitiligo Patients
Phase 2
Recruiting
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT20120215009014N283
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age of 12 to 70 years
Vitiligo lesions with at least one lesions on each sides
Involving at least 20% of the body surface
Exclusion Criteria
Malignant skin disease
Failure of previous radiotherapy
Pregnancy or breastfeeding
Hepatic or renal disease
Lupus Erythematosus
Photosensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of Vitiligo lesions. Timepoint: 3 months after the intervention. Method of measurement: With physical examination.
- Secondary Outcome Measures
Name Time Method